3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
8
Phase 1
8
Phase NA
1
Phase 3
1
Phase 1/2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
1
Interventions
Radiosurgery
28
Magnetic Resonance Spectroscopy
25
Blood Specimen Collection
20
Radiotherapy
19
Surveys and Questionnaires
18
Exercise
16
Early Intervention, Educational
16
Methods
15
Cyclophosphamide
15
Surgical Procedures, Operative
14
Standard of Care
14
Radiotherapy, Intensity-Modulated
14
Biopsy
13
Acupuncture Therapy
12
Interviews as Topic
11
Cisplatin
11
Filgrastim
10
Educational Status
10
Radiofrequency Ablation
9
Magnetic Resonance Imaging
9
Fluorodeoxyglucose F18
9
fludarabine phosphate
8
Radiation
8
Gemcitabine
8
X-Rays
7
Sorafenib
7
Practice Guidelines as Topic
7
Granulocyte Colony-Stimulating Factor
7
Colonoscopy
7
Capecitabine
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Terminated
×
dabrafenib
×
Clear all
NCT04801966
2023-05-10
TAILOR
Peter MacCallum Cancer Centre, Australia
Phase NA
Terminated
3 enrolled